UAE Left Ventricular Assist Devices (LVADs) Market Projections Indicate USD 511.22 Million Size by 2030

• Overview
• Table of Content
• Research Methodology
• Download Free Sample

The UAE Left Ventricular Assist Devices (LVADs) Market size was valued at around USD 391.29 million in 2024 and is projected to reach USD 511.22 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 4.45% during the forecast period, i.e., 2025-30, cites MarkNtel Advisors in the recent research report. Several strong forces propel the market for left ventricular assist devices in the United Arab Emirates. Most significantly, the various healthcare initiatives initiated by the UAE government, aim to improve cardiovascular care. Moreover, the UAE's growing heart failure rate has a substantial effect on the market expansion for left ventricular assist devices. Heart disease is the main reason of death in the United Arab Emirates with cardiovascular diseases accounting for 40% of all fatalities according to the Ministry of Health and Prevention. Advanced treatments like LVADs are becoming more in demand as the number of heart failure cases rises especially among the elderly.

Furthermore, technological improvements in LVADs have led to increased usage as they are now easier to implant, smaller, and more efficient. Furthermore, public and healthcare provider awareness of heart disease and LVAD technology has increased market acceptability especially as heart disease awareness campaigns multiply. In addition, the increased incidence of heart failure leads to the importance of LVADs in stabilizing patients until heart transplantation. Focused on improving access and quality of health services, the private healthcare sector is increasingly adopting LVADs, thereby expanding the scope of market access. Another untouched opportunity is the pediatric LVAD market in the UAE, where few solutions exist for younger patients who experience severe heart failure. As research and development continue to intensify, LVAD technology innovations are believed to further improve patient outcomes while boosting market growth. Post-implant care for LVAD patients with telemedicine and remote monitoring is also a promising opportunity to reduce hospital readmissions.

Moreover, the trend toward less invasive LVAD techniques is significant because they are less risky and require less recovery time. This trend is certain to continue as continuous-flow LVADs become more popular because of their effectiveness compactness and reduced complications. To guarantee better care of patients on LVAD hospitals in the United Arab Emirates are also using cutting-edge technologies like remote monitoring more frequently. Additionally, a greater emphasis on patient-centric care for transplants is reflected in the growing demand for LVADs that are customized to meet the needs of individual patients which improves survival rates, further states the research report, “UAE Left Ventricular Assist Devices (LVADs) Market Analysis, 2025”.

UAE Left Ventricular Assist Devices (LVADs) Market Segmentation Analysis

The Non-Pulsatile Flow Segment Holds the Largest Market Share

Based on the type of flow, the market is further bifurcated into Pulsatile Flow and Non-Pulsatile Flow. The Non-Pulsatile flow segment dominates the UAE LVADs market with a share of more than 70%. Non-pulsatile flow LVADs are preferred over pulsatile flow devices due to better reliability, smaller size, and improved patient outcomes. Such devices offer more stable and efficient blood circulation that would decrease the possibility of conditions like device malfunction or thrombosis, which is better for long-term usage. Moreover, non-pulsatile flow LVADs are more user-friendly, allowing patients greater comfort and mobility, factors that are important for long-term support. Technological advancements further enhance the appeal of the devices, thereby reducing costs and making non-pulsatile flow systems more accessible.

Bridge to Transplantation is the Most Preferred Application

The Bridge to Transplantation segment is the largest application in the UAE LVADs market and accounts for up to 75% of the market. It is used in patients suffering from advanced stages of heart failure and who are awaiting heart transplantation. LVADs in BTT applications provide vital short-term circulatory support to stabilize the patients until a suitable donor heart is available. Given the growing shortage of donor organs and increasing prevalence of heart failure, BTT has become an essential solution in managing patients on the transplant list. In the UAE, the number of heart transplant programs is growing, with BTT being the most commonly used practice in various hospitals, like Cleveland Clinic Abu Dhabi, that are equipped with the latest cardiac care facilities. The demand for BTT is seen to increase as the rates of heart failure rise and more patients require urgent heart transplant support.

Competitive Landscape

With strategic initiatives such as mergers, collaborations, and acquisitions, the leading market companies, including Abbott Laboratories, Cadrenal Therapeutics, Fresenius Medical Care AG & Co. KgaA, Abiomed Inc., Teleflex Incorporated, SynCardia Systems, CardiacAssist, Inc., Jarvik 2000, Reliant Heart, Edwards Lifesciences, GE Healthcare, and others are looking forward to strengthening their market positions.

Key Questions Answered in the Research Report

1. What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
2. What are the trends influencing the current scenario of the market?
3. What key factors would propel and impede the industry across the country?
4. How has the industry been evolving in terms of geography & service adoption?
5. What key factors would propel and impede the industry across the country?
6. How have buying behavior, customer inclination, and expectations from product manufacturers been evolving during 2020-30?
7. Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?